Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
100%
Follicular Lymphoma
65%
Lymphoma
57%
Progression-Free Survival
48%
Survival
47%
Rituximab
38%
Ovarian Neoplasms
36%
Non-Hodgkin's Lymphoma
33%
Mantle-Cell Lymphoma
24%
B-Cell Lymphoma
19%
Neoplasms
19%
Molecular Epidemiology
16%
Therapeutics
14%
Confidence Intervals
14%
Peripheral T-Cell Lymphoma
14%
B-Lymphocytes
14%
Single Nucleotide Polymorphism
12%
T-Lymphocytes
12%
Recurrence
11%
Hodgkin Disease
11%
Vincristine
11%
B-Cell Chronic Lymphocytic Leukemia
11%
Serum
11%
Doxorubicin
10%
Cyclophosphamide
10%
epratuzumab
10%
Cohort Studies
9%
Genes
9%
Ovarian Epithelial Carcinoma
9%
Biomarkers
9%
Prednisone
9%
T-Cell Lymphoma
9%
Bendamustine Hydrochloride
8%
Drug Therapy
8%
Anthracyclines
8%
Cytokines
8%
Clinical Trials
7%
Light
7%
Heterografts
7%
Quality of Life
7%
Population
6%
Germinal Center
6%
Prospective Studies
6%
Carcinoma
6%
Glioma
6%
Survivors
6%
Mutation
6%
Regulatory T-Lymphocytes
5%
Genetic Variation
5%
Platinum
5%